1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Activated Partial Thromboplastin Test Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Optical Technology 1.2.3 Mechanical Technology 1.2.4 Electrochemical Technology 1.3 Market by Application 1.3.1 Global Activated Partial Thromboplastin Test Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Activated Partial Thromboplastin Test Market Perspective (2017-2028) 2.2 Activated Partial Thromboplastin Test Growth Trends by Region 2.2.1 Activated Partial Thromboplastin Test Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Activated Partial Thromboplastin Test Historic Market Size by Region (2017-2022) 2.2.3 Activated Partial Thromboplastin Test Forecasted Market Size by Region (2023-2028) 2.3 Activated Partial Thromboplastin Test Market Dynamics 2.3.1 Activated Partial Thromboplastin Test Industry Trends 2.3.2 Activated Partial Thromboplastin Test Market Drivers 2.3.3 Activated Partial Thromboplastin Test Market Challenges 2.3.4 Activated Partial Thromboplastin Test Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Activated Partial Thromboplastin Test Players by Revenue 3.1.1 Global Top Activated Partial Thromboplastin Test Players by Revenue (2017-2022) 3.1.2 Global Activated Partial Thromboplastin Test Revenue Market Share by Players (2017-2022) 3.2 Global Activated Partial Thromboplastin Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Activated Partial Thromboplastin Test Revenue 3.4 Global Activated Partial Thromboplastin Test Market Concentration Ratio 3.4.1 Global Activated Partial Thromboplastin Test Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Activated Partial Thromboplastin Test Revenue in 2021 3.5 Activated Partial Thromboplastin Test Key Players Head office and Area Served 3.6 Key Players Activated Partial Thromboplastin Test Product Solution and Service 3.7 Date of Enter into Activated Partial Thromboplastin Test Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Activated Partial Thromboplastin Test Breakdown Data by Type 4.1 Global Activated Partial Thromboplastin Test Historic Market Size by Type (2017-2022) 4.2 Global Activated Partial Thromboplastin Test Forecasted Market Size by Type (2023-2028) 5 Activated Partial Thromboplastin Test Breakdown Data by Application 5.1 Global Activated Partial Thromboplastin Test Historic Market Size by Application (2017-2022) 5.2 Global Activated Partial Thromboplastin Test Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Activated Partial Thromboplastin Test Market Size (2017-2028) 6.2 North America Activated Partial Thromboplastin Test Market Size by Country (2017-2022) 6.3 North America Activated Partial Thromboplastin Test Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Activated Partial Thromboplastin Test Market Size (2017-2028) 7.2 Europe Activated Partial Thromboplastin Test Market Size by Country (2017-2022) 7.3 Europe Activated Partial Thromboplastin Test Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Activated Partial Thromboplastin Test Market Size (2017-2028) 8.2 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Country (2017-2022) 8.3 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Activated Partial Thromboplastin Test Market Size (2017-2028) 9.2 Latin America Activated Partial Thromboplastin Test Market Size by Country (2017-2022) 9.3 Latin America Activated Partial Thromboplastin Test Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Activated Partial Thromboplastin Test Market Size (2017-2028) 10.2 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2017-2022) 10.3 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Horiba International 11.1.1 Horiba International Company Detail 11.1.2 Horiba International Business Overview 11.1.3 Horiba International Activated Partial Thromboplastin Test Introduction 11.1.4 Horiba International Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.1.5 Horiba International Recent Development 11.2 Bio-Rad Laboratories 11.2.1 Bio-Rad Laboratories Company Detail 11.2.2 Bio-Rad Laboratories Business Overview 11.2.3 Bio-Rad Laboratories Activated Partial Thromboplastin Test Introduction 11.2.4 Bio-Rad Laboratories Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.2.5 Bio-Rad Laboratories Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Detail 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Activated Partial Thromboplastin Test Introduction 11.3.4 Johnson & Johnson Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.3.5 Johnson & Johnson Recent Development 11.4 Siemens Medical Solutions 11.4.1 Siemens Medical Solutions Company Detail 11.4.2 Siemens Medical Solutions Business Overview 11.4.3 Siemens Medical Solutions Activated Partial Thromboplastin Test Introduction 11.4.4 Siemens Medical Solutions Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.4.5 Siemens Medical Solutions Recent Development 11.5 Abbott Laboratories 11.5.1 Abbott Laboratories Company Detail 11.5.2 Abbott Laboratories Business Overview 11.5.3 Abbott Laboratories Activated Partial Thromboplastin Test Introduction 11.5.4 Abbott Laboratories Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.5.5 Abbott Laboratories Recent Development 11.6 BioMeriux 11.6.1 BioMeriux Company Detail 11.6.2 BioMeriux Business Overview 11.6.3 BioMeriux Activated Partial Thromboplastin Test Introduction 11.6.4 BioMeriux Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.6.5 BioMeriux Recent Development 11.7 Eiken Chemical 11.7.1 Eiken Chemical Company Detail 11.7.2 Eiken Chemical Business Overview 11.7.3 Eiken Chemical Activated Partial Thromboplastin Test Introduction 11.7.4 Eiken Chemical Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.7.5 Eiken Chemical Recent Development 11.8 Life Technologies 11.8.1 Life Technologies Company Detail 11.8.2 Life Technologies Business Overview 11.8.3 Life Technologies Activated Partial Thromboplastin Test Introduction 11.8.4 Life Technologies Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.8.5 Life Technologies Recent Development 11.9 Danaher 11.9.1 Danaher Company Detail 11.9.2 Danaher Business Overview 11.9.3 Danaher Activated Partial Thromboplastin Test Introduction 11.9.4 Danaher Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.9.5 Danaher Recent Development 11.10 BD 11.10.1 BD Company Detail 11.10.2 BD Business Overview 11.10.3 BD Activated Partial Thromboplastin Test Introduction 11.10.4 BD Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.10.5 BD Recent Development 11.11 Roche Diagnostics 11.11.1 Roche Diagnostics Company Detail 11.11.2 Roche Diagnostics Business Overview 11.11.3 Roche Diagnostics Activated Partial Thromboplastin Test Introduction 11.11.4 Roche Diagnostics Revenue in Activated Partial Thromboplastin Test Business (2017-2022) 11.11.5 Roche Diagnostics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Activated Partial Thromboplastin Test Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Optical Technology Table 3. Key Players of Mechanical Technology Table 4. Key Players of Electrochemical Technology Table 5. Global Activated Partial Thromboplastin Test Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Activated Partial Thromboplastin Test Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Activated Partial Thromboplastin Test Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Activated Partial Thromboplastin Test Market Share by Region (2017-2022) Table 9. Global Activated Partial Thromboplastin Test Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Activated Partial Thromboplastin Test Market Share by Region (2023-2028) Table 11. Activated Partial Thromboplastin Test Market Trends Table 12. Activated Partial Thromboplastin Test Market Drivers Table 13. Activated Partial Thromboplastin Test Market Challenges Table 14. Activated Partial Thromboplastin Test Market Restraints Table 15. Global Activated Partial Thromboplastin Test Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Activated Partial Thromboplastin Test Market Share by Players (2017-2022) Table 17. Global Top Activated Partial Thromboplastin Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activated Partial Thromboplastin Test as of 2021) Table 18. Ranking of Global Top Activated Partial Thromboplastin Test Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Activated Partial Thromboplastin Test Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Activated Partial Thromboplastin Test Product Solution and Service Table 22. Date of Enter into Activated Partial Thromboplastin Test Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Activated Partial Thromboplastin Test Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2017-2022) Table 26. Global Activated Partial Thromboplastin Test Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2023-2028) Table 28. Global Activated Partial Thromboplastin Test Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Activated Partial Thromboplastin Test Revenue Market Share by Application (2017-2022) Table 30. Global Activated Partial Thromboplastin Test Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Activated Partial Thromboplastin Test Revenue Market Share by Application (2023-2028) Table 32. North America Activated Partial Thromboplastin Test Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Activated Partial Thromboplastin Test Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Activated Partial Thromboplastin Test Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Activated Partial Thromboplastin Test Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Activated Partial Thromboplastin Test Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Activated Partial Thromboplastin Test Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2023-2028) & (US$ Million) Table 42. Horiba International Company Detail Table 43. Horiba International Business Overview Table 44. Horiba International Activated Partial Thromboplastin Test Product Table 45. Horiba International Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 46. Horiba International Recent Development Table 47. Bio-Rad Laboratories Company Detail Table 48. Bio-Rad Laboratories Business Overview Table 49. Bio-Rad Laboratories Activated Partial Thromboplastin Test Product Table 50. Bio-Rad Laboratories Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 51. Bio-Rad Laboratories Recent Development Table 52. Johnson & Johnson Company Detail Table 53. Johnson & Johnson Business Overview Table 54. Johnson & Johnson Activated Partial Thromboplastin Test Product Table 55. Johnson & Johnson Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 56. Johnson & Johnson Recent Development Table 57. Siemens Medical Solutions Company Detail Table 58. Siemens Medical Solutions Business Overview Table 59. Siemens Medical Solutions Activated Partial Thromboplastin Test Product Table 60. Siemens Medical Solutions Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 61. Siemens Medical Solutions Recent Development Table 62. Abbott Laboratories Company Detail Table 63. Abbott Laboratories Business Overview Table 64. Abbott Laboratories Activated Partial Thromboplastin Test Product Table 65. Abbott Laboratories Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 66. Abbott Laboratories Recent Development Table 67. BioMeriux Company Detail Table 68. BioMeriux Business Overview Table 69. BioMeriux Activated Partial Thromboplastin Test Product Table 70. BioMeriux Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 71. BioMeriux Recent Development Table 72. Eiken Chemical Company Detail Table 73. Eiken Chemical Business Overview Table 74. Eiken Chemical Activated Partial Thromboplastin Test Product Table 75. Eiken Chemical Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 76. Eiken Chemical Recent Development Table 77. Life Technologies Company Detail Table 78. Life Technologies Business Overview Table 79. Life Technologies Activated Partial Thromboplastin Test Product Table 80. Life Technologies Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 81. Life Technologies Recent Development Table 82. Danaher Company Detail Table 83. Danaher Business Overview Table 84. Danaher Activated Partial Thromboplastin Test Product Table 85. Danaher Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 86. Danaher Recent Development Table 87. BD Company Detail Table 88. BD Business Overview Table 89. BD Activated Partial Thromboplastin Test Product Table 90. BD Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 91. BD Recent Development Table 92. Roche Diagnostics Company Detail Table 93. Roche Diagnostics Business Overview Table 94. Roche Diagnostics Activated Partial Thromboplastin TestProduct Table 95. Roche Diagnostics Revenue in Activated Partial Thromboplastin Test Business (2017-2022) & (US$ Million) Table 96. Roche Diagnostics Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Activated Partial Thromboplastin Test Market Share by Type: 2021 VS 2028 Figure 2. Optical Technology Features Figure 3. Mechanical Technology Features Figure 4. Electrochemical Technology Features Figure 5. Global Activated Partial Thromboplastin Test Market Share by Application in 2021 & 2028 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Others Case Studies Figure 9. Activated Partial Thromboplastin Test Report Years Considered Figure 10. Global Activated Partial Thromboplastin Test Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Activated Partial Thromboplastin Test Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Activated Partial Thromboplastin Test Market Share by Region: 2021 VS 2028 Figure 13. Global Activated Partial Thromboplastin Test Market Share by Players in 2021 Figure 14. Global Top Activated Partial Thromboplastin Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activated Partial Thromboplastin Test as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Activated Partial Thromboplastin Test Revenue in 2021 Figure 16. North America Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Activated Partial Thromboplastin Test Market Share by Country (2017-2028) Figure 18. United States Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Activated Partial Thromboplastin Test Market Share by Country (2017-2028) Figure 22. Germany Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Activated Partial Thromboplastin Test Market Share by Region (2017-2028) Figure 30. China Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Activated Partial Thromboplastin Test Market Share by Country (2017-2028) Figure 38. Mexico Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Activated Partial Thromboplastin Test Market Share by Country (2017-2028) Figure 42. Turkey Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Activated Partial Thromboplastin Test Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Horiba International Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 45. Bio-Rad Laboratories Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 46. Johnson & Johnson Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 47. Siemens Medical Solutions Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 48. Abbott Laboratories Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 49. BioMeriux Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 50. Eiken Chemical Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 51. Life Technologies Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 52. Danaher Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 53. BD Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 54. Roche Diagnostics Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2017-2022) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Horiba International Bio-Rad Laboratories Johnson & Johnson Siemens Medical Solutions Abbott Laboratories BioMeriux Eiken Chemical Life Technologies Danaher BD Roche Diagnostics